Sergio Giralt

87PUBLICATIONS

414CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer diagnosisPsychology of ageingCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (87)

Sort by Publication Date:

|Jun 15, 2026

Daratumumab therapy for refractory immune cytopenias after allogeneic hematopoietic cell transplantation.

|Apr 12, 2026

Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma.

Hamza Hashmi, Tara Sebastian, Sridevi Rajeeve

|Apr 09, 2026

Feasibility Study: Early Experiences With a Cancer Center's Virtual Expert Medical Opinion Program.

Allison Lipitz-Snyderman, Susan Chimonas, Brendan Raftery

|Apr 09, 2026

Eligibility versus appropriateness in allogeneic HCT.

Mohamed L Sorror, Andrew S Artz, Rebecca L Olin

|Feb 17, 2026

IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM.

Kylee H Maclachlan, Carlyn Rose Tan, Tala Shekarkhand

|Jan 05, 2026

Time of day of CAR T-cell infusion and outcomes in large B-cell lymphoma.

Danny Luan, Ori Ben Valid, Ofrat Beyar-Katz

Pageof 15

Frequent Collaborators

42 joint publications

Miguel-Angel Perales

32 joint publications

Gunjan Shah

31 joint publications

Heather Landau

26 joint publications

Urvi Shah

24 joint publications

Malin L Hultcrantz

22 joint publications

Kylee Maclachlan

22 joint publications

Carlyn Tan

21 joint publications

Neha Korde

20 joint publications

Alexander M Lesokhin

18 joint publications

Sham Mailankody